Efficacy Study of Ecabet Ophthalmic Solution in Dry Eye Disease

Bausch + Lomb

Status and phase: Completed; Phase 2

Conditions: Dry Eye Disease

Treatments: Drug: ecabet ophthalmic solution; Drug: placebo

Study type: Interventional

Funder types: Industry

Identifiers

NCT00667004

CL-S&E-1107071-P

Details and patient eligibility

About

Efficacy study of ecabet ophthalmic solution in dry eye disease

Enrollment: 183 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Diagnosed with dry eye disease

Exclusion criteria

• Dry eye disease secondary to surgery

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

183 participants in 2 patient groups, including a placebo group

1

Experimental group

Description:

ecabet ophthalmic solution

Treatment:

Drug: ecabet ophthalmic solution

2

Placebo Comparator group

Description:

Placebo comparator

Treatment:

Drug: placebo